Scinai Immunotherapeutics (SCNI) Other Operating Expenses (2014 - 2024)

Scinai Immunotherapeutics has reported Other Operating Expenses for 7 years, with the latest figure at $8.4 million in Q4 2024.

• Quarterly Other Operating Expenses rose 93322.22% year-over-year to $8.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $8.4 million (up 28.96% YoY) and the FY2025 annual result came in at $39000.0, changed N/A from the prior year.
• Other Operating Expenses grew to $8.4 million in Q4 2024 per SCNI's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $55.6 million in Q3 2020 and troughed at -$16.9 million in Q3 2022.
• A 5-year average of $4.2 million and a median of -$6000.0 in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2021 and 2024: Other Operating Expenses tumbled 100.3% in 2021, then soared 93322.22% in 2024.
• Over 5 years, Other Operating Expenses stood at $4.0 million in 2020, then sank by 100.3% to -$12000.0 in 2021, then jumped by 31333.33% to $3.7 million in 2022, then slumped by 100.24% to -$9000.0 in 2023, then jumped by 93322.22% to $8.4 million in 2024.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $8.4 million, -$1.9 million, and $124000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.